Scarica l'app Stockscreener
1.79
7.83%
0.13
Dopo l'orario di chiusura:
1.79
Precedente Chiudi:
$1.66
Aprire:
$1.5735
Volume 24 ore:
6,433
Relative Volume:
0.09
Capitalizzazione di mercato:
$5.30M
Reddito:
$16,600
Utile/perdita netta:
$-6.65M
Rapporto P/E:
-0.5303
EPS:
-3.3752
Flusso di cassa netto:
$-6.32M
1 W Prestazione:
+14.74%
1M Prestazione:
-6.28%
6M Prestazione:
+38.76%
1 anno Prestazione:
-53.75%
Intervallo 1D:
$1.5735
$1.80
Intervallo di 1 settimana:
$1.565
$1.80
Portata 52W:
$0.97
$7.91
Cardio Diagnostics Holdings Inc Stock (CDIO) Company Profile
Nome
Cardio Diagnostics Holdings Inc
Settore
Industria
Telefono
855-226-9991
Indirizzo
311 W. SUPERIOR STREET, CHICAGO
Compare CDIO vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CDIO
Cardio Diagnostics Holdings Inc
|
1.79 | 4.79M | 16,600 | -6.65M | -6.32M | -3.3752 |
VRTX
Vertex Pharmaceuticals Inc
|
496.07 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
784.36 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
865.04 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
205.15 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
348.27 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Cardio Diagnostics Holdings Inc Borsa (CDIO) Ultime notizie
Cardio Diagnostics Holdings Inc. Revenue Breakdown – BOATS:CDIOW - TradingView
CDIO|Cardio Diagnostics Holdings Inc|Price:1.600|Chg%:+0.050 - TradingKey
Cardio Diagnostics Holdings Inc (CDIO) Balance Sheet - TradingKey
Cardio Diagnostics Holdings Inc (CDIO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cardio Diagnostics Holdings Inc (CDIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cardio Diagnostics Holdings Inc. Revenue Breakdown – NASDAQ:CDIOW - TradingView
Cardio Diagnostics Holdings Inc (CDIO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CDIO|Cardio Diagnostics Holdings Inc|Price:1.550|Chg%:-0.050 - TradingKey
Cardio Diagnostics Hldgs Market Sentiment - Benzinga España
Cardio Diagnostics Holdings Inc (CDIO) Institutional Confidence - TradingKey
Cardio Diagnostics Holdings Inc (CDIO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cardio Diagnostics (CDIO) details AI-driven heart disease testing and capital raises - Stock Titan
What's Driving Cardio Diagnostics Holdings' Recent Stock Surge - Kavout | AI
Cardio Diagnostics Leverages AI and Precision Medicine to Address Growing Cardiovascular Disease Market - citybuzz -
Price to book forward of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIOW - TradingView
Cardio Diagnostics (NASDAQ: CDIO) eyes private share issuance of up to $10M - Stock Titan
Price to earnings forward of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIOW - TradingView
Enterprise value to EBIT forward of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIOW - TradingView
Heart Attack Diagnostic Market Report Examines Leading Companies And Growth Opportunities - openPR.com
Enterprise value to revenue forward of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIO - TradingView
CDIO Q1 2025 Earnings: Narrower-than-Expected Loss Despite Stock PullbackDividend Growth Analysis - DonanımHaber
CDIO Should I Buy - Intellectia AI
Form 4 Cardio Diagnostics Holdings Inc For: 2 July By Investing.com - Investing.com India
Cardio Diagnostics (CDIO) director receives 2,854 stock options at $2.19 strike - Stock Titan
Cardio Diagnostics (NASDAQ: CDIO) director awarded 2,854 options at $2.19 - Stock Titan
Cardio Diagnostics (CDIO) director granted 2,854 stock options at $2.19 strike price - Stock Titan
Cardio Diagnostics (CDIO) director receives 2,854 stock options at $2.19 - Stock Titan
Cardio Diagnostics Holdings (CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health Plans - NewMediaWire
Cardio Diagnostics Holdings (NASDAQ: CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health Plans - Barchart.com
CDIO Q1 2025 Earnings: EPS Beats Estimates by 47.2% as Company Advances Diagnostic PlatformAnalyst Coverage Count - dars.gov.et
Cardio Diagnostics Highlights Precision Cardiovascular Tools for Employers and Health Plans at National Conferences - citybuzz -
Cardio Diagnostics Holdings (CDIO) Leverages Epigenetics to Reveal Hidden Heart Disease Risks - Yahoo Finance
Cardio Diagnostics Holdings (NASDAQ: CDIO) Leverages Epigenetics to Reveal Hidden Heart Disease Risks - TradingView
Cardio Diagnostics Uses Epigenetics to Uncover Hidden Heart Disease Risks - MEXC
Cardio Diagnostics Holdings (CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease Detection - Yahoo Finance
Cardio Diagnostics Holdings (NASDAQ: CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease Detection - TipRanks
Cardio Diagnostics Holdings Warrant (CDIOW) Holds Steady at $0.01 Amid Minimal MovementValue Area Low - dars.gov.et
CDIO Q1 2025 Earnings: EPS Surpasses Consensus by Over 47% as Company Advances Diagnostic PlatformDownward Estimate Revision - dars.gov.et
Cardio Diagnostics (CDIO) Holds Near $2.01 Amid Modest Decline – Key Levels in FocusGamma Flip Level - DonanımHaber
Cardio Diagnostics Unveils Molecular Test to Address Blind Spots in Coronary Heart Disease Detection - citybuzz -
Cardio Diagnostics Holdings Inc. Actuals & Estimates (NASDAQ:CDIO) - TradingView
Cardio Diagnostics Holdings (CDIO) Expands Coverage of Precision Cardiovascular Tests Through Atlas Healthcare Physicians - Yahoo Finance
Cardio Diagnostics Holdings (NASDAQ: CDIO) Expands Coverage of Precision Cardiovascular Tests Through Atlas Healthcare Physicians - TradingView
Atlas Healthcare will cover Cardio Diagnostics heart tests for members - Stock Titan
Cardio Diagnostics Company Profile & Introduction - Moomoo
Atlas Healthcare Physicians to Cover Cardio Diagnostics’ Precision Cardiovascular Medicine Tests Across Its Network - Business Wire
Cardio Diagnostics Holdings (CDIO) Targets a $393B Heart Disease Problem With Epigenetics and AI - Yahoo Finance
Cardio Diagnostics Holdings (NASDAQ: CDIO) Targets a $393B Heart Disease Problem with Epigenetics and AI - TradingView
Cardio Diagnostics Targets $393 Billion Heart Disease Problem with Epigenetics and AI - citybuzz -
Cardio Diagnostics Holdings Inc (CDIOW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cardio Diagnostics Holdings Inc (CDIOW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cardio Diagnostics Holdings Inc Azioni (CDIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.84%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):